ROBERT SALTER: Open Payments
NPI 1598865842 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 18 payments from 6 companies in 2025. Trend: 2023 $848 · 2024 $479 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $116 |
| Janssen Biotech, Inc. | 3 | $66 |
| GENZYME CORPORATION | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 3 | $19 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, ENTYVIO, VOQUEZNA, REZDIFFRA.
Industry payments across LA — which companies pay providers there.
